The 20 Best Renal Oncocytoma Doctors Near Me in Ypsilanti, MI

Jan Akervall is an Otolaryngologist practicing medicine in Ypsilanti, Michigan. Dr. Akervall is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Acinic Cell Carcinoma of Salivary Glands, Laryngectomy, and Gastrostomy.

Thomas Weimert is an Otolaryngologist practicing medicine in Ypsilanti, Michigan. Dr. Weimert is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His clinical expertise encompasses Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Jones Syndrome, DFNB1, and Infant Hearing Loss. Dr. Weimert is currently accepting new patients.

Joseph Seymour is an Otolaryngologist practicing medicine in Ypsilanti, Michigan. Dr. Seymour is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Nasal Polyps, Infant Hearing Loss, DFNB1, Jones Syndrome, and Laryngectomy.

Laurence Ho is a General Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Empyema, Sinusitis, and Nasal Septal Hematoma.

Meredith Montero is a General Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Montero is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Laryngeal Nerve Damage, Infant Hearing Loss, DFNB1, and Jones Syndrome.

Dr. Mark Prince earned his medical degree at Dalhousie University Medical School in Halifax, Nova Scotia, and then served with the Canadian Armed Forces as a medical officer, receiving specialized training in hyperbaric and diving medicine. Dr. Prince returned to Dalhousie University and completed a residency in otolaryngology head and neck surgery, followed by a two-year fellowship in advanced head and neck oncology and microvascular reconstructive surgery at the University of Michigan. He joined the University of Michigan faculty in 2000, and is actively involved in resident and medical student education, serving as his department's residency program director. Dr. Prince served as the chief of the section of otolaryngology at the Ann Arbor VA Medical Center until 2009, he continues to serve there as an active staff member. His research laboratory published the first report of the identification of cancer stem cells in head and neck squamous cell cancer, and continues to conduct research in this exciting field. Dr. Prince is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, and Gastrostomy. Dr. Prince is board certified in Otolaryngology-Head & Neck Surgery.

Keith Casper is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Casper is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy. Dr. Casper is board certified in Otolaryngology-Head & Neck Surgery.

Andrew G. Shuman, MD, FACS, HEC-C is a head & neck cancer surgeon and a tenured Professor at the University of Michigan Medical School. He serves as chief of the clinical ethics service for Michigan Bioethics.He is the Assistant Dean for Veterans Affairs University of Michigan Medical School and the Associate Chief of Staff-Education at the VA Ann Arbor Health System, where he directs the educational experience for 1600 pre- and post-doctoral trainees and learners.Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His work involves defining the conceptual dimensions of “surgical ethics,” applying his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work from NIH, the VA and societal grants, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine, JAMA and Nature Medicine. He has acted as PI on projects focused on cancer treatment decision-making, precision oncology and drug shortages, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. He was closely involved in Michigan Medicine and the VA's pandemic response, as well as at the state and national level on the ethics of scarce resource allocation including testifying in front of the United States Senate.Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts. Dr. Shuman is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Salivary Gland Tumors, and Laryngectomy. Dr. Shuman is board certified in Otolaryngology-Head & Neck Surgery.

Khaled Hafez is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Hafez is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Hafez is board certified in Urology.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Molly Neal is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Neal is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Glossectomy, and Laryngectomy.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.

David Forner is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Forner is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Branchial Cleft Cyst, and Laryngectomy.

Marisa Buchakjian is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Buchakjian is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Tongue Cancer, Throat Cancer, Laryngeal Cancer, Laryngectomy, and Tissue Biopsy. Dr. Buchakjian is board certified in Otolaryngology-Head & Neck Surgery.

Alice Semerjian is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Semerjian is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Semerjian is board certified in Urology.

Brent B. Ward, DDS, MD, is the Chalmers J. Lyons Endowed Professor in the Department of Oral and Maxillofacial Surgery/Hospital Dentistry within the School of Dentistry, and Professor in the Section of Oral and Maxillofacial Surgery in the Department of Surgery at the University of Michigan. Dr. Ward is a graduate of Brigham Young University and the University of Southern California, Los Angeles School of Dentistry. He received his medical degree and completed his postgraduate training, including residency and fellowship, at the University of Michigan, joining the faculty in 2003. He is the Associate Program Director of the Oral/Head & Neck Oncologic and Microvascular Reconstructive Surgery Fellowship within the Section of Oral and Maxillofacial Surgery. Dr. Ward has been recognized as a professional leader by numerous organizations. He is a past president and the current Executive Director of the American Academy of Craniomaxillofacial Surgeons. He has held multiple leadership positions in the American Association of Oral and Maxillofacial Surgeons (AAOMS), including Chair of the Committee on Education and Training, the Committee on Oral, Head and Neck Oncology & Reconstructive Surgery, and the Special Committee on Student Recruitment and Residency Program Strategies. He currently chairs the Oral and Maxillofacial Surgery Foundation Research Committee and is a member of the Editorial Board of the Journal of Oral and Maxillofacial Surgery. Dr. Ward is the recipient of the 2025 Presidential Achievement Award from AAOMS. Throughout his career, Dr. Ward has actively blended his clinical expertise with research supported by entities including the National Institutes of Health, the Department of Defense, the OMS Foundation, and the Osteo Science Foundation, in the areas of cancer, reconstruction, and pain control. He specializes clinically in cancer and precancerous conditions, as well as major pathology and reconstruction of the structures of the face, mouth, and jaws resulting from cancer, trauma, or congenital defects. Dr. Ward is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Tongue Cancer, Mouth Ulcers, Gastrostomy, and Glossectomy. Dr. Ward is board certified in Oral & Maxillofacial Surgery.

Ganesh S. Palapattu, MD, FACS is The George F. and Sandy G. Valassis Professor and Chair of the Department of Urology. He joined the University of Michigan Department of Urology as Associate Professor and Chief of Urologic Oncology in the Fall of 2012. Prior to this he was the Chief of Urologic Oncology at Houston Methodist Hospital in Houston, Texas. Dr. Palapattu has held faculty appointments at the University of Rochester School of Medicine in Rochester, NY where he was also Assistant Residency Program Director and Weill Cornell Medical College/The Houston Methodist Hospital.Dr. Palapattu was born in Toronto, Canada where he developed a passion for street hockey. At the age of 9, his family moved to Houston, Texas where he picked up playing the French horn. Dr. Palapattu graduated from the University of Texas at Austin with a B.A. degree in the Humanities and subsequently attended Baylor College of Medicine. Dr. Palapattu received his surgical/urological training at the David Geffen School of Medicine at UCLA and further specialty training in urologic oncology at Johns Hopkins. He and his wife, Anu, whom he met at UT Austin, have 2 young children. The Palapattu family is enthusiastic about taking advantage of the many outdoor activities the Ann Arbor area affords.When not working, Dr. Palapattu enjoys spending time with his family, traveling and playing/watching sports. Go Blue!. Dr. Palapattu is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Palapattu is board certified in Urology.

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Morgan is board certified in Urology.

Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation. Dr. Salami is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Salami is board certified in Urology.

Michael Englesbe, MD, FACS is the Cyrenus G Darling Sr M.D. and Cyrenus G Darling Jr M.D. Professor of Surgery at the University of Michigan in the Section of Transplantation Surgery. Dr. Englesbe received his undergraduate degree at Yale University in New Haven, Connecticut in 1993. He went on to obtain his medical degree in 1997 from the Robert Wood Johnson Medical School and completed his general surgery residency at the University of Michigan Health System in 2004. From 2000 to 2002, Dr. Englesbe did a surgical research post-doctoral fellowship at the University of Washington Medical Center in Seattle, Washington. He does kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults.Education Focus:Dr. Englesbe particularly enjoys working with undergraduate students, medical students, and young physician trainees. He serves as the Department of Surgery Vice Chair for Resident Mentorship and the University of Michigan Medical School Capstone Curriculum Director.Clinical Specialization:Dr. Englesbe specializes in kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults. Dr. Englesbe is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hernia, Liver Failure, End-Stage Renal Disease (ESRD), Liver Transplant, and Kidney Transplant. Dr. Englesbe is board certified in Surgery.